Cancer has become a real menace to American society with at least 40% of all Americans standing a chance of being diagnosed with one or more types of cancer at one point or another in their lives. The American Cancer Institute estimates that 14.5 million Americans are struggling with cancer and projects that the number will soar to 19 million by 2024. The disease has affected almost every member of the American society in one manner or another, either directly or indirectly. It is under this backdrop that Tempus has been founded. Tempus is a cancer treatment company majoring in the development of data-enabled precision medicine. Not surprising, it was not until the wife of one of the co-founders, Eric Lefkofsky’s wife was diagnosed with cancer that he saw the need for such a company which provides such a valuable service and more information click here.
Despite strides taken in the uptake of the electronic health records technology, Mr. Lefkofsky has been taken aback by the slow adoption of technology in the health care sector. Although health institutions have spent plenty of time and energy in the collection and storage of critical patient data, there has never been created any system that can take advantage of this and put such data to good use. Tempus was set up to to fill this gap specifically. It’s meant to develop methods to harness this information and enable the creation of treatment methods that use the data to create distinct approaches to each patient’s conditions.
Before joining Tempus, co-founder Eric Lefkofsky had served as the chief executive officer for Groupon, a fast growing collective action company which he co-founded in 2007. He has had a prolific business career spanning all the way back to his college years in the University of Michigan. Most of his investments have been in the technology world, the key of which is Groupon, which was declared the fastest growing company in the world by Forbes Magazine in 2010. These business ventures have made Mr. Lefkofsky a respected member of society in Michigan and placed him on a high pedestal and learn more about Eric.
His investment in Tempus speaks further to his high regard for human life. Other philanthropic works include the Lefkofsky Foundation and his membership to the Giving Pledge.